Healthcare -
Biotechnology - NASDAQ - US
$ 5.16
-2.27 %
$ 46 M
Market Cap
-19.85
P/E
ICCC - OTHER CURRENT ASSETS
Other Current Assets ICCC - ImmuCell Corporation
494 K
LAST VALUE
35.57%
2 YEAR CAGR
28.22%
5 YEAR CAGR
10.98%
10 YEAR CAGR